Total Payments
$48,218
2024 Payments
$9,415
Companies
13
Transactions
75
Payment Breakdown by Category
Other$22,226 (46.1%)
Research$12,750 (26.4%)
Consulting$10,365 (21.5%)
Food & Beverage$1,847 (3.8%)
Travel$930.76 (1.9%)
Education$99.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,626 | 12 | 44.9% |
| Unspecified | $12,750 | 12 | 26.4% |
| Consulting Fee | $10,365 | 5 | 21.5% |
| Food and Beverage | $1,847 | 35 | 3.8% |
| Travel and Lodging | $930.76 | 9 | 1.9% |
| Honoraria | $600.00 | 1 | 1.2% |
| Education | $99.00 | 1 | 0.2% |
Payments by Type
General
$35,468
63 transactions
Research
$12,750
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $18,295 | 28 | $0 (2024) |
| Novo Nordisk Inc | $14,044 | 17 | $0 (2022) |
| BioMarin Pharmaceutical Inc. | $6,936 | 5 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $3,566 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $3,315 | 3 | $0 (2024) |
| Azurity Pharmaceuticals, Inc. | $1,575 | 1 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $161.38 | 2 | $0 (2022) |
| Dexcom, Inc. | $122.14 | 1 | $0 (2018) |
| TOLMAR Pharmaceuticals, Inc. | $106.59 | 2 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $38.09 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,415 | 12 | SANOFI-AVENTIS U.S. LLC ($3,315) |
| 2023 | $6,204 | 6 | PFIZER INC. ($6,204) |
| 2022 | $8,501 | 11 | BioMarin Pharmaceutical Inc. ($4,745) |
| 2021 | $6,331 | 4 | PFIZER INC. ($4,140) |
| 2019 | $1,148 | 8 | PFIZER INC. ($1,148) |
| 2018 | $8,358 | 11 | Novo Nordisk Inc ($8,211) |
| 2017 | $8,260 | 23 | Novo Nordisk Inc ($5,744) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2024 | PFIZER INC. | NGENLA (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: NGENLA CLINICAL PUBLICATION PROGRAM • Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Consulting Fee | Cash or cash equivalent | $3,198.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $87.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | Cash or cash equivalent | $28.68 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/24/2024 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: SOMATROGON CLINICAL PUBLICATION PROGRAM | ||||||
| 07/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| Category: Rare Disease | ||||||
| 05/03/2024 | PFIZER INC. | NGENLA (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: NGENLA CLINICAL PUBLICATION PROGRAM • Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 05/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $105.84 | General |
| Category: Rare Disease | ||||||
| 04/06/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $172.27 | General |
| Category: Rare Disease | ||||||
| 03/19/2024 | PFIZER INC. | — | — | In-kind items and services | $940.00 | Research |
| Study: SOMATROGON CLINICAL PUBLICATION PROGRAM | ||||||
| 02/20/2024 | Azurity Pharmaceuticals, Inc. | TRIPTODUR (Drug) | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/26/2024 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $17.04 | General |
| 12/05/2023 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: SOMATROGON CLINICAL PUBLICATION PROGRAM | ||||||
| 09/14/2023 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: SOMATROGON CLINICAL PUBLICATION PROGRAM | ||||||
| 09/14/2023 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: SOMATROGON CLINICAL PUBLICATION PROGRAM | ||||||
| 05/22/2023 | PFIZER INC. | GENOTROPIN (Drug) | Consulting Fee | Cash or cash equivalent | $4,162.00 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 05/08/2023 | PFIZER INC. | — | — | In-kind items and services | $940.00 | Research |
| Study: SOMATROGON CLINICAL PUBLICATION PROGRAM | ||||||
| 04/18/2023 | PFIZER INC. | GENOTROPIN (Drug) | Food and Beverage | In-kind items and services | $112.36 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 12/05/2022 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: SOMATROGON CLINICAL PUBLICATION PROGRAM | ||||||
| 11/03/2022 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 07/27/2022 | PFIZER INC. | GENOTROPIN (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 07/27/2022 | PFIZER INC. | GENOTROPIN (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 05/27/2022 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $20.17 | General |
| 03/19/2022 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: SOMATROGON CLINICAL PUBLICATION PROGRAM | ||||||
| 02/16/2022 | BioMarin Pharmaceutical Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SOMATROGON CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $6,730 | 8 |
| MOD4023 OPKO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,140 | 2 |
| NGENLA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,880 | 2 |
About Dr. Joel Steelman, MD
Dr. Joel Steelman, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790813137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Steelman, MD has received a total of $48,218 in payments from pharmaceutical and medical device companies, with $9,415 received in 2024. These payments were reported across 75 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,626).
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Pediatric Endocrinology
- Location Fort Worth, TX
- Active Since 02/28/2007
- Last Updated 04/19/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1790813137
Products in Payments
- Norditropin (Drug) $13,955
- GENOTROPIN (Drug) $5,545
- TZIELD (Biological) $3,315
- Strensiq (Drug) $2,138
- NGENLA (Drug) $1,880
- TRIPTODUR (Drug) $1,575
- STRENSIQ (Biological) $1,358
- Increlex-Somatuline (Drug) $141.21
- Dexcom CGM (Device) $122.14
- FENSOLVI (Drug) $106.59
- Kanuma (Drug) $53.52
- ZOMACTON (Drug) $38.09
- Triptodur (Drug) $26.63
- t-slim insulin pump (Device) $15.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Fort Worth
Anjanette Tan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $303,907
Endocrinology, Diabetes & Metabolism $303,907
Dr. Chris Bajaj, D.o, D.O
Endocrinology, Diabetes & Metabolism — Payments: $268,642
Endocrinology, Diabetes & Metabolism $268,642
Dr. David Wilson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $232,835
Endocrinology, Diabetes & Metabolism $232,835
Dr. Kenneth Mair, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $107,541
Endocrinology, Diabetes & Metabolism $107,541
Saraswathi Saiprasad, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $2,910
Endocrinology, Diabetes & Metabolism $2,910
Dr. Franklin Gluck, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,599
Endocrinology, Diabetes & Metabolism $1,599